Vimarsana
Biggest News Aggregation in the World

Sharay Setti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sharay Setti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sharay Setti Today - Breaking & Trending Today

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton's Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer's Disease Seite 1 - Vimarsana News

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton's Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer's Disease Seite 1

Published: November 15, 2023

15.11.2023 - Data presented at Society for Neuroscience Annual Meeting 2023BOTHELL, Wash., Nov. 15, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore ... Seite 1

Source: wallstreet-online.de
Related Topics:
United StatesSharay SettiAthira PharmaSociety For Neuroscience Annual MeetingAthira Pharma IncSociety For Neuroscience Sfn Annual MeetingKevin ChurchNeuroscience Annual MeetingAnnual MeetingChief Scientific OfficerSmall Molecule Positive ModulatorProtects Against AmyloidPathological AlterationsDisease Models In VitroSenior ScientistAthira Pharma ChartThira Pharma KursThira Pharma Aktie
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates - Vimarsana News

Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates

Published: November 9, 2023

Continues to report clinical and preclinical findings supporting the potential benefits of its small molecule therapeutic candidates targeting the...

Source: businessinsider.com
Related Topics:
United StatesJulie RathbunSharay SettiMark LittonAthira PharmaWei WuWaltere Washington Convention CenterDrug AdministrationDevelopment Of Novel Therapies For NeurodegenerativeSociety For NeuroscienceClinical Development Pipeline ProgramsSecurities ExchangeAlzheimer Association International ConferenceAthira Pharma IncDevelopment Rd ExpensesExchange CommissionChief Executive OfficerGlobal Statistical TestLabel ExtensionUpcoming PresentationsAssociation International ConferenceAnnual Clinical TrialsAnnual NortheastConvention CenterNovel Therapies
Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences - Vimarsana News

Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences

Published: March 6, 2023

06.03.2023 - BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that ... Seite 1

Source: wallstreet-online.de
Related Topics:
Vastra Gotalands LanAthira PharmaWei WuSharay SettiAnne BerthiaumeAthira Pharma IncAmerican Society For Experimental NeurotherapeuticsKevin ChurchInternational Conference On AlzheimerPresent Data Supporting Therapeutic PotentialUpcoming Scientific ConferencesAmerican SocietyChief Scientific OfficerSmall Molecule Positive ModulatorHepatocyte Growth FactorAmyotrophic LateralPipeline PresentationsSenior ScientistPersistent Therapeutic EffectsRat ModelDiabetic NeuropathicPrimary NeuronExhibition AreaFosgonimeton Promotes SurvivalReduces Protein Pathology